Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (TNDM) manufactures insulin pumps and diabetes management technology, with its dominant political signal being $1.38M in annual physician payments (2024) and two congressional purchases in 2025-2026.
BusinessWhat TNDM does
Tandem Diabetes Care designs, manufactures, and markets insulin delivery systems, including the t:slim X2 insulin pump with automated insulin dosing software. Revenue is derived from pump sales, disposable supplies, and software services. The company operates in the highly regulated medical device sector under FDA oversight and relies on physician adoption and insurance reimbursement.
Lifetime Government AwardsTNDM federal contracts
TNDM doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding TNDM
Politicians Trading TNDMMembers of Congress with recent TNDM positions
Congressional TradesWho in Congress is trading TNDM
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting TNDMLive legislation impacting this stock
Political ProfileWhere TNDM sits in Washington
[object Object]
STRUCTURAL: High regulatory density (85) from healthcare sector and multiple bill impacts (8 bills, avg impact ~$15.6M). EVIDENTIARY: Two congressional traders made purchases in 2025-2026 (3 transactions total), and corporate insiders made 3 buys in 2025 totaling ~$442.7K (Recent corp insider Form 4 buys). Net: No lobbying or donations, but physician payments ($1.38M in 2024) indicate commercial influence, not political. Mixed signals with slight bullish tilt from trades.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
FDA regulatory changes for medical device classification or software as a medical deviceFDA"Inferred from sector; no direct RPC field for FDA actions, but high regulatory density score based on healthcare sector and device nature."
-
Medicare/Medicaid reimbursement rate cuts for durable medical equipmentCMS"Inferred from sector; bill_impacts show multiple healthcare bills with revenue impact, indicating legislative exposure."
Regulatory opportunities
-
Expanded coverage for continuous glucose monitors and automated insulin delivery systems under MedicareCMS"Inferred from sector; bill_impacts could include positive reimbursement changes, but no carveouts or specific pro-TNDM bills in bill_carveouts."
Capitol Hill AlliesChampions & critics
Congressional champions
- Unknown (Rep. C001123) Unknown
- Unknown (Rep. G000583) Unknown
Congressional critics
- No specific congressional critics identified.
Live signals + predictions for TNDM — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades TNDM
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord